Cytosorbents - 48 Year Dividend Yield History | CTSO

Historical dividend payout and yield for Cytosorbents (CTSO) since 1971. The current TTM dividend payout for Cytosorbents (CTSO) as of March 25, 2019 is $0.00. The current dividend yield for Cytosorbents as of March 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.241B $0.023B
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
ResMed (RMD) United States $14.350B 27.21
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Phibro Animal Health (PAHC) United States $1.283B 18.45
Meridian Bioscience (VIVO) United States $0.715B 21.30
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
United-Guardian (UG) United States $0.087B 19.84